Glazer Capital LLC’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,330,102
| Closed | -$13.4M | – | 519 |
|
|
2022
Q4 | $13.4M | Buy |
1,330,102
+243,601
| +22% | +$2.46M | 0.35% | 105 |
|
|
2022
Q3 | $10.8M | Buy |
1,086,501
+576,567
| +113% | +$5.71M | 0.2% | 162 |
|
|
2022
Q2 | $5M | Buy |
509,934
+331,439
| +186% | +$3.25M | 0.12% | 235 |
|
|
2022
Q1 | $1.75M | Sell |
178,495
-8,622
| -5% | -$84.6K | 0.05% | 266 |
|
|
2021
Q4 | $1.81M | Buy |
187,117
+176,529
| +1,667% | +$1.71M | 0.04% | 339 |
|
|
2021
Q3 | $103K | Sell |
10,588
-497
| -4% | -$4.84K | ﹤0.01% | 753 |
|
|
2021
Q2 | $107K | Buy |
+11,085
| New | +$107K | ﹤0.01% | 803 |
|